Company: DMAAR
Filing Date: 2025-01-22
Form Type: POS AM
Source: 0001213900-25-005176
Chunk: 253

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-22
Form: POS AM
Chunk 253
---
 to purchase up to 3,000,000 additional units at the initial public offering price per unit, less underwriting discounts and commissions, solely to cover over -allotments, if any. The purchase price to be paid per additional unit shall be equal to the initial public offering price of one unit, less the underwriting discount. Discounts, Commissions and Reimbursement The following table shows the per unit and total underwriting discounts and commissions to be paid to the underwriters. Such amounts are shown assuming both no exercise and full exercise of the underwriters’ over -allotmentoption:

|             |     | No Exercise |           |     | Full Exercise |           |
|:------------|:----|:------------|----------:|:----|:--------------|----------:|
| Per unit(1) |     | $           |      0.35 |     | $             |      0.35 |
| Total(1)    |     | $           | 7,000,000 |     | $             | 8,050,000 |

____________ (1)Includes $0.05 per unit sold in the base offering, or 0.5% of the gross proceeds of the offering, or $1,000,000 in the aggregate (or up to $1,150,000 if the over -allotmentoption is exercised in full), is payable upon the closing of this offering. Also includes $0.30 per unit sold in the base offering, or 3.0% of the gross proceeds of the offering, or $6,000,000 (or up to $6,900,000 if the over -allotmentoption is exercised in full) in the aggregate, of which 25.0% will be adjusted net of redemptions (i.e., for purposes of calculating the deferred underwriting commission net of redemptions, 25.0% of the deferred underwriting commissions will determined by the dollar amount that is product of (i) 3.0% multiplied by the product of the number of unredeemed public shares, multiplied by $10.00 and (ii) 25.0%), payable to the underwriters in this offering, for deferred underwriting commissions to be placed in a trust account located in the United States and released to the underwriters only upon the completion of an initial business combination. The table does not include certain other fees and expenses payable (or securities issuable) to the underwriters in connection